Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,230,845
in 7 filings, $1.6M under 10b5-1 plans

Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hohl Benjamin −$887K CHIEF FINANCIAL OFFICER sold 32% of stake
  2. Collins Helen Louise −$737K CHIEF MEDICAL OFFICER sold 38% of stake
  3. Garland J. Scott −$607K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2020-03-16 PFIZER INC 10% owner Conversion · Series Seed Preferred Stock −478,749 0
2020-03-16 PFIZER INC 10% owner Conversion · Series A Preferred Stock −5,470,492 0
2020-03-16 PFIZER INC 10% owner Conversion · Series B Preferred Stock −1,894,444 0
2020-03-12 Bonita David P Director Purchase +937,500 $16.00 $15.0M 937,500
2020-03-12 ORBIMED ADVISORS LLC Director Purchase +937,500 $16.00 $15.0M 937,500

Page 42 of 42 · 825 trades